Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Allen W. M. Recollections of My Life with Progesterone. Gynecol. Invest., 1974; 5:142–182.

Allen W. M. The isolation of crystalline progestin. Science, 1935; 82 (2118):89–93.

Allred K. F., et al. Trigonelline Is a Novel Phytoestrogen in Coffee Beans. J. Nutr., 2009; 139:1833–1838.

Al-Sabbagh M., Lam E., Brosens J. J. Mechanisms of endometrial progesterone resistance. Mol. Cel. Endocrinol., 2012; 358: 208–215.

Ambhaikar M., Pur C. Cell surface binding sites for progesterone on human spermatozoa. Mol. Hum. Reprod., 1998; 4:413–421.

American College of Obstetricians and Gynecologist. Use of progesterone to reduce preterm birth: ACOG committee opinion, No. 2919. Obstet Gynecol, 2003; 102:1115–1116.

American College of Obstetricians and Gynecologist. Use of progesterone to reduce preterm birth: ACOG committee opinion, No. 419. Obstet. Gynecol., 2008; 112:963.

American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin. Management of recurrent early pregnancy loss. Int. J. Gynecol. Obstet., 2002; 78:179–190.

American College of Obstetricians and Gynecologists (ACOG). Early pregnancy loss. ACOG technical bulletin. No. 212. Washington DC: American College of Obstetricians and Gynecologists, 1995.

American College of Obstetricians and Gynecologists. Compounded bioidentical hormones. ACOG Committee Opinion. No. 322. Obstet. Gynecol., 2005; 106 (1):1139–1140.

American College of Obstetricians and Gynecologists. Premenstrual Syndrome. ACOG Practice Bulletin. No. 15. Washington, DC: American College of Obstetricians and Gynecologists, 2000.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association, 2000.

Andersen A. N., et al. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod, 2002; 17:357–361.

Andréen L., et al. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas, 2006; 54:238–244.

Angst J., et al. The epidemiology of premenstrual psychological symptoms. Acta Psychiatr. Scand., 2001; 104:110–116.

Anserini P., et al. Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol., 2001; 53:297–301.

Antonipillai J., et al. The origin of plasma deoxycorticosterone in men and in women during the menstrual cycle. J. Clin. Endocrinol. Metab., 1983; 56:93–98.

Aoki K., et al. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet, 1995; 345:1340–1342.

Apter D., Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J. Clin. Endocrinol. Metab.,1983; 57:82–86.

Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin. Endocrinol. (Oxf), 1980; 12:107–120.

Archer D. F., et al. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am. J. Obstet. Gynecol., 1995; 173:471–477; discussion, 477–478.

Archer D. F. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women. Menopause, 2001; 8:245–251.

Arck P. Stress and embryo implantation. J. Gynecol. Obstet. Biol. Reprod., 2004; 33:S40-S42.

Armon L., Eisenbach M. Behavioral Mechanism during Human Sperm Chemotaxis: Involvement of Hyperactivation. PLoS ONE, 2011; 6 (12):e28359.

Arredondo F., Noble L. S. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006; 24:33–39.

Arthur A. A., Daniel J. C. Progesterone regulation of blastokinin production and maintenance of rabbit blastocysts transferred into uteri of castrate recipients. Fert. Steril., 1972; 23:115–122.

Asso D. The Real Menstrual Cycle. New York: John Wiley & Sons; 1983.

Attia G. R., et al. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab., 2000; 85:2897–2902.

Aufrere M. B., Benson H. Progesterone: an overview and recent advances. J. Pharm. Sci. 1976; 65:783–800.

Aupperlee M., et al. Progestins and breast cancer. Breast Disease, 2005; 24:37–57.

Ayoubi J. M., et al. Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans. Fertil. Steril., 2001; 76:736–740.

Azem F., et al. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecological Endocrinology, 2008; 24 (7):368–372.

Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online, 2004; 8:644–648.

Backer Jr. M. H. Isopregnenone (Duphaston): a new progestational agent. Obstet. Gynecol., 1962; 19:724–729.